Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-23-026730

Options or other derivatives

  • Chief Financial Officer acquired 198,126 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Little Paul Sean Chief Financial Officer 2023-05-01 Grant or award · Stock Option (right to buy) +198,126 198,126 D
Loading xslF345X04/doc4.xml…